The M&A wheel continues to turn in med-tech, spurred on in
part by the reality that making money the old fashioned way ("earning
it", for those too young to remember the John Houseman commercials) is
getting harder and harder. The latest rumor, that Stryker (NYSE: SYK ) was taking a look at Smith & Nephew (NYSE: SNN )
, was not only confirmed by Stryker but goes to show the depth of
consolidation in med-tech as maturing markets leave fewer and fewer
opportunities for sub-scale players.
Read more here:
Why Stryker Should Buy Smith & Nephew
No comments:
Post a Comment